Skip to main content
Erschienen in: Clinical Research in Cardiology 4/2020

29.06.2019 | Original Paper

Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure—bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial

verfasst von: Simone Frea, Stefano Pidello, Alessandra Volpe, Federico Giovanni Canavosio, Alessandro Galluzzo, Virginia Bovolo, Antonio Camarda, Pier Giorgio Golzio, Fabrizio D’Ascenzo, Serena Bergerone, Mauro Rinaldi, Fiorenzo Gaita

Erschienen in: Clinical Research in Cardiology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Diuretic resistance is a common issue in patients with acute decompensation of advanced chronic heart failure (ACHF). The aim of this trial was to compare boluses and continuous infusion of furosemide in a selected population of patients with ACHF and high risk for diuretic resistance.

Methods

In this single-centre, double-blind, double-dummy, randomized trial, we enrolled 80 patients admitted for acute decompensation of ACHF (NYHA IV, EF ≤ 30%) with criteria of high risk for diuretic resistance (SBP ≤ 110 mmHg, wet score ≥ 12/18, and sodium ≤ 135 mMol/L). Patients were assigned in a 1:1 ratio to receive furosemide by bolus every 12 h or by continuous infusion. Diuretic treatment and dummy treatment were prepared by a nurse unassigned to patients’ care. The study treatment was continued for up to 72 h. Coprimary endpoints were total urinary output and freedom from congestion at 72 h.

Results

80 patients were enrolled with 40 patients in each treatment arm. Mean daily furosemide was 216 mg in continuous-infusion arm and 195 mg in the bolus intermittent arm. Freedom from congestion (defined as jugular venous pressure of < 8 cm, with no orthopnea and with trace peripheral edema or no edema) occurred more in the continuous infusion than in the bolus arm (48% vs. 25%, p = 0.04), while total urinary output after 72 h was 8612 ± 2984 ml in the bolus arm and 10,020 ± 3032 ml in the continuous arm (p = 0.04). Treatment failure occurred less in the continuous-infusion group (15% vs. 38%, p = 0.02), while there was no significant difference between groups in the incidence of worsening of renal function.

Conclusion

Among patients with acute decompensation of ACHF and high risk of diuretic resistance, continuous infusion of intravenous furosemide was associated with better decongestion.

DRAIN trial

ClinicalTrials.gov number NCT03592836.

Graphic abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Neuberg GW, Miller AB, O’Connor CM, Belkin RN, Carson PE, Cropp AB, Frid DJ, Nye RG, Pressler ML, Wertheimer JH, Packer M (2002) Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144:31–38PubMedCrossRef Neuberg GW, Miller AB, O’Connor CM, Belkin RN, Carson PE, Cropp AB, Frid DJ, Nye RG, Pressler ML, Wertheimer JH, Packer M (2002) Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144:31–38PubMedCrossRef
2.
Zurück zum Zitat Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7(2):261–270PubMedCrossRef Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7(2):261–270PubMedCrossRef
4.
Zurück zum Zitat Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB (2010) Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail 16:188–193PubMedCrossRef Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB (2010) Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail 16:188–193PubMedCrossRef
5.
Zurück zum Zitat Allen LA, Turer AT, DeWald T et al (2010) Continuous versus bolus dosing of furosemide for patients hospitalized for heart failure. Am J Cardiol 105(12):1794–1797PubMedPubMedCentralCrossRef Allen LA, Turer AT, DeWald T et al (2010) Continuous versus bolus dosing of furosemide for patients hospitalized for heart failure. Am J Cardiol 105(12):1794–1797PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805PubMedPubMedCentralCrossRef Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Kuriyama A, Urushidani S (2019) Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev 24(1):31–39PubMedCrossRef Kuriyama A, Urushidani S (2019) Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev 24(1):31–39PubMedCrossRef
8.
Zurück zum Zitat Metra M, Ponikowski P, Dickstein K et al (2007) Advanced chronic heart failure: a position statement from the study group on advanced heart failure of the heart failure association of the ESC. Eur J Heart Fail 9:684–694PubMedCrossRef Metra M, Ponikowski P, Dickstein K et al (2007) Advanced chronic heart failure: a position statement from the study group on advanced heart failure of the heart failure association of the ESC. Eur J Heart Fail 9:684–694PubMedCrossRef
9.
Zurück zum Zitat Gheorghiade M, Follath F, Ponikowski P et al (2010) European society of cardiology; European society of intensive care medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine. Eur J Heart Fail 12:423–433CrossRef Gheorghiade M, Follath F, Ponikowski P et al (2010) European society of cardiology; European society of intensive care medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine. Eur J Heart Fail 12:423–433CrossRef
10.
Zurück zum Zitat ESC Scientific Document Group (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Eur Heart J 37:2129–2200CrossRef ESC Scientific Document Group (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Eur Heart J 37:2129–2200CrossRef
11.
Zurück zum Zitat Ambrosio G, Di Lenarda A, Fedele F, Gabrielli D, Metra M, Oliva F, Perna G, Senni M, De Maria R (2009) Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment. Giomale Ital Cardiol 10:422–433 Ambrosio G, Di Lenarda A, Fedele F, Gabrielli D, Metra M, Oliva F, Perna G, Senni M, De Maria R (2009) Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment. Giomale Ital Cardiol 10:422–433
12.
Zurück zum Zitat Frea S, Pidello S, Canavosio FG et al (2015) Clinical assessment of hypoperfusion in acute heart failure: evergreen or antique? Circ J 79:398–405PubMedCrossRef Frea S, Pidello S, Canavosio FG et al (2015) Clinical assessment of hypoperfusion in acute heart failure: evergreen or antique? Circ J 79:398–405PubMedCrossRef
13.
Zurück zum Zitat Frea S, Bovolo V, Pidello S, Canavosio FG, Botta M, Bergerone S, Gaita F (2015) Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome? Int J Cardiol 15(195):53–60CrossRef Frea S, Bovolo V, Pidello S, Canavosio FG, Botta M, Bergerone S, Gaita F (2015) Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome? Int J Cardiol 15(195):53–60CrossRef
14.
Zurück zum Zitat Frea S, Centofanti P, Pidello S, Giordana F, Bovolo V, Baronetto A, Franco B, Cingolani MM, Attisani M, Morello M, Bergerone S, Rinaldi M, Gaita F (2018) Noninvasive assessment of hemodynamic status in Heart-Ware left ventricular assist device patients: validation of an echocardiographic approach. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2018.01.026 PubMedCrossRef Frea S, Centofanti P, Pidello S, Giordana F, Bovolo V, Baronetto A, Franco B, Cingolani MM, Attisani M, Morello M, Bergerone S, Rinaldi M, Gaita F (2018) Noninvasive assessment of hemodynamic status in Heart-Ware left ventricular assist device patients: validation of an echocardiographic approach. JACC Cardiovasc Imaging. https://​doi.​org/​10.​1016/​j.​jcmg.​2018.​01.​026 PubMedCrossRef
15.
Zurück zum Zitat Frea S, Pidello S, Bovolo V, Iacovino C, Franco E, Pinneri F, Galluzzo A, Volpe A, Visconti M, Peirone A, Morello M, Bergerone S, Gaita F (2016) Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure. Eur J Heart Fail 18(5):564–572PubMedCrossRef Frea S, Pidello S, Bovolo V, Iacovino C, Franco E, Pinneri F, Galluzzo A, Volpe A, Visconti M, Peirone A, Morello M, Bergerone S, Gaita F (2016) Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure. Eur J Heart Fail 18(5):564–572PubMedCrossRef
16.
Zurück zum Zitat Valente M, Voors A, Damman K et al (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293PubMedCrossRef Valente M, Voors A, Damman K et al (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293PubMedCrossRef
17.
Zurück zum Zitat Matsue Y, Ter Maaten JM, Suzuki M, Goldsmith SR et al (2017) Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction. Clin Res Cardiol 106(10):802–812PubMedPubMedCentralCrossRef Matsue Y, Ter Maaten JM, Suzuki M, Goldsmith SR et al (2017) Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction. Clin Res Cardiol 106(10):802–812PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Bekfani T, Westphal F, Schulze PC (2018) Therapeutic options in advanced heart failure. Clin Res Cardiol 107(2):114–119PubMedCrossRef Bekfani T, Westphal F, Schulze PC (2018) Therapeutic options in advanced heart failure. Clin Res Cardiol 107(2):114–119PubMedCrossRef
19.
Zurück zum Zitat Schulz KF, Altman DG, Moher D, For the CONSORT Group (2010) CONSORT statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332PubMedPubMedCentralCrossRef Schulz KF, Altman DG, Moher D, For the CONSORT Group (2010) CONSORT statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Llorens P, Miró O, Herrero P et al (2014) Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial. Emerg Med J 31:706–713PubMedCrossRef Llorens P, Miró O, Herrero P et al (2014) Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial. Emerg Med J 31:706–713PubMedCrossRef
21.
Zurück zum Zitat Ng KT, Yap JLL (2018) Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials. Anaesthesia 73(2):238–247PubMedCrossRef Ng KT, Yap JLL (2018) Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials. Anaesthesia 73(2):238–247PubMedCrossRef
22.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596PubMedPubMedCentralCrossRef Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5(1):54–62PubMedCrossRef Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5(1):54–62PubMedCrossRef
24.
Zurück zum Zitat Brisco MA, Zile MR, Hanberg JS et al (2016) Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial. J Card Fail. 22:753–760PubMedPubMedCentralCrossRef Brisco MA, Zile MR, Hanberg JS et al (2016) Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial. J Card Fail. 22:753–760PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Sanjay S, Ra Annigeri, Seshadri R et al (2008) The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease. Nephrology 13(3):247–250PubMedCrossRef Sanjay S, Ra Annigeri, Seshadri R et al (2008) The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease. Nephrology 13(3):247–250PubMedCrossRef
26.
Zurück zum Zitat Ng T, Konopka E, Hyderi AF et al (2013) Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther 18:345–356PubMedCrossRef Ng T, Konopka E, Hyderi AF et al (2013) Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther 18:345–356PubMedCrossRef
27.
Zurück zum Zitat Sica D (2003) Metolazone and its role in edema management. CHF 9:100–105PubMed Sica D (2003) Metolazone and its role in edema management. CHF 9:100–105PubMed
Metadaten
Titel
Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure—bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial
verfasst von
Simone Frea
Stefano Pidello
Alessandra Volpe
Federico Giovanni Canavosio
Alessandro Galluzzo
Virginia Bovolo
Antonio Camarda
Pier Giorgio Golzio
Fabrizio D’Ascenzo
Serena Bergerone
Mauro Rinaldi
Fiorenzo Gaita
Publikationsdatum
29.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 4/2020
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-019-01521-y

Weitere Artikel der Ausgabe 4/2020

Clinical Research in Cardiology 4/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.